ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2015

Jul 17, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INOTEK PHARMACEUTICALS CORP (ITEK)
CIK: 0001281895
Period of Report: 2015-07-14

Reporting Person: Devon Park Associates, L.P. (10% Owner)
Reporting Person: Devon Park Associates, LLC (10% Owner)
Reporting Person: Kantesaria Devang (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-07-14	Common Stock	M	9857	$4.342	Acquired	3253566	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-07-14	Stock Options (Right to Buy)	$4.342	M	9857	Disposed	2024-08-28	Common Stock (9857)	Indirect

Footnotes

F1: The 9,857 shares of Common Stock were assigned by Dr. Devang Kantesaria to Devon Park Associates, L.P. immediately upon exercise of the underlying options. Dr. Kantesaria, along with Messrs. Marc Ostro and Christopher Moller (collectively, the "Founding Members"), are the founding and managing members of Devon Park Associates, LLC, which is the general partner of Devon Park Associates, L.P. Dr. Kantesaria is contractually obligated to assign the value of these securities to Devon Park Associates, L.P. Each Founding Member further disclaims beneficial ownership of these securities, except to the extent of such Founding Member's pecuniary interest therein, and this report shall not be deemed an admission that the Founding Members are the beneficial owner of such securities for Section16 or any other purposes.

F2: Fully vested.

F3: Options for the purchase of 9,857 shares of Common Stock were held directly by Dr. Kantesaria and assigned to Devon Park Associates, L.P. immediately upon exercise.